The HMG-CoA Reductase Inhibitor Rosuvastatin and the Angiotensin Receptor Antagonist Candesartan Attenuate Atherosclerosis in an Apolipoprotein E-Deficient Mouse Model of Diabetes via Effects on Advanced Glycation, Oxidative Stress and Inflammation
Diabetologia - Germany
doi 10.1007/s00125-008-1060-6
Full Text
Open PDFAbstract
Available in full text
Date
July 2, 2008
Authors
Publisher
Springer Science and Business Media LLC